Center for Medicinal Cannabis Research (CMCR) October 18, 2019

October 18, 2019:

The Center for Medicinal Cannabis Research (CMCR) is hosting a one-day symposium celebrating the pioneers and exploring the progress, promise, and challenges of medicinal cannabis research.

REGISTRATION REQUIRED. To register, CLICK HERE

During the symposium we will be honoring two pioneers in medicinal cannabinoid research: Raphael Mechoulam, PhD (Hebrew University) – Dr. Mechoulam has made groundbreaking discoveries in the field of cannabinoid chemistry since the 1960s. He coined the term “cannabinoid”. In 1964, Dr. Mechoulam’s laboratory first identified and synthesized delta-9-tetrahydrocannabinol (“THC”), the main psychoactive component of cannabis. Since then, his team has gone on to identify the structure of most of the cannabinoids and their metabolites and to discover the endogenous cannabinoids anandamide and 2-arachidonylglycerol (2-AG). An author of more than 300 publications, Dr. Mechoulam holds over 20 patents. Known for his scientific vision and warmth, we are pleased to honor his achievements and outstanding contribution to the field of medicinal cannabis with the Pioneer in Medicinal Cannabis Award.

Geoffrey Guy, MBBS (GW Pharmaceuticals) – Dr. Guy founded GW Pharmaceuticals and has served as its Chairman since 1998. Dr. Guy created Epidiolex, the first formulation of cannabidiol to receive approval from the US Food and Drug Administration, and Sativex. He continues to lead innovation and new product discovery for cannabinoid-based medicine. He has been the physician in charge of over 300 clinical studies including pharmacokinetic, pharmacodynamic, and dose-ranging studies, controlled clinical trials, and large scale multi-centered studies and clinical surveys. An innovator in medical research and global drug development for his entire career, the CMCR is pleased to honor his achievements and outstanding contribution to the field of medicinal cannabis with the CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics.

SYMPOSIUM AGENDA – Friday, October 18, 2019

7:30 AMBREAKFAST

8:00 AM

Introduction/Overview

Igor Grant, MD, CMCR Director, UC San Diego

8:15 AM

Pioneer in Medicinal Cannabis Research Award

Raphael Mechoulam, PhD, Hebrew University of Jerusalem

8:50 AM

Advancing Cannabis and Cannabinoids as Therapeutics Award

Presentation on Cannabinoid Therapeutics: Harnessing the medicinal properties of cannabis: from plant to medicine

Geoffrey Guy, MBBS, GW Pharmaceuticals

SESSION 1The Anti-Inflammatory Properties of Cannabinoids 9:35 AMTransdermal cannabidiol in animal model of arthritis

Karin Westlund-High, PhD, University of New Mexico

9:50 AMThe immunomodulary effect of cannabis use in HIVJennifer Manuzak, PhD, University of Miami Miller School of Medicine10:05 AMDiscussion/Future Directions 10:15 AMBREAK SESSION 2The Promise of Cannabidiol 10:30 AMCannabidiol and receptor physiologyFabricio Moreira, PhD, Universidade Federal de Minas Gerais, Brazil10:45 AMCannabidiol in reducing alcohol cravingMichael Taffe, PhD, UC San Diego11:00 AMCannabidiol in reducing nicotine cravingOlivier George, PhD, UC San Diego11:15 AMDiscussion/Future Directions SESSION 3The Potential Opioid Sparing Effects of Cannabinoids 11:30 AMThe endocannabinoid system and painAron Lichtman, PhD, Virginia Commonwealth University11:45 AMHuman lab experiments of cannabinoids and painZiva Cooper, PhD, UCLANOONDoes cannabis moderate opioid use in chronic pain?Michelle Sexton, ND, UC San Diego12:15 PMDiscussion/Future Directions 12:30 PMLUNCH and POSTER SESSION SESSION 4Safeguarding, Educating, and Learning from Cannabis use in the Public Sphere 1:30 PMRecent findings on the effects of medicinal and recreational cannabis laws on youth consumptionDenise Walker, PhD, University of Washington1:45 PMImpact and detection of cannabis impaired drivingThomas Marcotte, PhD, UC San Diego2:00 PMWhat are the promises and limitations of various cannabinoid testing platformsRobert Fitzgerald, PhD, UC San Diego2:15 PMDiscussion/Future Directions SESSION 5Panel Discussion – State of California ApproachDiscussants2:30 PM Lori Ajax, Chief, California Bureau of Cannabis Control Tom Lackey, California Assemblyman District 363:15 PMBREAK SESSION 6Achieving Priorities in Medicinal Cannabis Research 3:30 PMIntroductionIgor Grant, MD, CMCR Director, UC San Diego3:40 PMPublic-private partnerships to advance cannabis and cannabinoid based medicines Gail Taylor, BSc, PhD, FSB, UC Davis and University of Southampton3:55 PMPanel DiscussionDiscussants Perspectives from NIDA and the drug supply programsSteve Gust, PhD, NIDA Issues in receiving an IND for human cannabinoid studiesDominic Chiapperino, PhD, FDA Legislative initiatives to facilitate medicinal cannabinoid research

Trelaine Ito, Office of US Senator Brian Schatz

Perspectives and opportunity from industry and philanthropy Industry perspectives: USAAlice Mead, JD, GW Pharmaceuticals Perspectives from non-profits dedicated to research and educationPelin Thorogood, Wholistic Research and Education Foundation4:55 PMClosing RemarksIgor Grant, MD, CMCR Director, UC San Diego5:00 PMADJOURN

REGISTRATION REQUIRED. To register, CLICK HERE

Location:  UC San Diego's Atkinson Hall, San Diego, California

FRIDAY, OCTOBER 18, 2019

8:00am – 5:00pm

Breakfast at 7:30am, lunch included

About the CMCR

Contact Us

HOTELS NEARBY

Estancia La Jolla Hotel & Spa – (Web Link: UCSD Symposium Room Rate)

9700 N Torrey Pines Road, La Jolla, CA 92037; Telephone: (858) 550-1000

Hyatt Regency La Jolla at Aventine

3777 La Jolla Village Drive, San Dieog, CA 92122; Telephone: (858) 552-1234

Hotel La Jolla, Curio Collection by Hilton

7955 La Jolla Shores Drive, La Jolla, CA 92037; Telephone: (858) 551-3600